Atlas Venture Opportunity Fund I, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/01/16

Trade details

Type: Insider sale
Amount: $1,362.42
Shares · price: 1,566 sh · $0.87 a share
Held after: 2,021,836 sh
Stock: Xilio Therapeutics XLO
Person: Atlas Venture Opportunity Fund I10% Owner
Trade date: 24/01/11
Filed: 24/01/16
Days to filing: 5 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/12~24/02/10

Atlas Venture Opportunity Fund I's recent trades

Atlas Venture Opportunity Fund IShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$72.4K
912 sh
$72.4K
Filed 09/04
Traded 09/04
Atlas Venture Opportunity Fund IShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$224.9K
2,810 sh
$224.9K
Filed 09/03
Traded 09/03
Atlas Venture Opportunity Fund IShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$2.1M
26,552 sh
$2.1M
Filed 09/02
Traded 09/02
Atlas Venture Opportunity Fund IShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$8.4M
322,465 sh
$8.4M
Filed 08/14
Traded 08/14
Atlas Venture Opportunity Fund IShareholder
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 plan
Dyne Therapeutics
DYN
$1.7M
63,643 sh
$1.7M
Filed 08/13
Traded 08/13